Madeleine C. Coleman

Madeleine Coleman practices at MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth.

Madeleine Coleman's NPI, 1083103832, was assigned on May 8, 2018. Madeleine Coleman holds Maine license MD25736.

Madeleine Coleman's primary practice is MaineHealth Maine Medical Center, at 22 Bramhall St, Portland, ME 04102 in Cumberland County. The practice phone is (207) 662-0111.

Madeleine Coleman's primary practice is MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Madeleine Coleman to 1 more medical group, named with a free account. Madeleine Coleman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Madeleine Coleman practices. Vendor and product names are available with a free account.

Internal medicine is Madeleine Coleman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Madeleine Coleman's licenses on file in 2 states: Maine and Connecticut.

CMS data shows 348 Medicare services from Madeleine Coleman across 6 procedure codes in 2024, for 133 Medicare patients. Medicare paid $25,897 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Madeleine Coleman in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madeleine Coleman's median patient age at 72, with 45% women.

In 2024, Madeleine Coleman wrote 162 Medicare Part D claims for 51 patients. 80% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $58 in total drug cost. In 2021, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Madeleine Coleman for performance year 2024, reported through an alternative payment model (APM). Madeleine Coleman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Madeleine Coleman in 2017. Madeleine Coleman's most frequent co-authors are Saroj Davi Kunnakkat and Catherine Lushbough, MD.